Financial Performance - The company's revenue for Q3 2023 reached ¥197,009,839.57, representing a 17.03% increase year-over-year[5] - Net profit attributable to shareholders was ¥42,300,540.88, up 20.88% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥36,434,788.69, reflecting a 34.60% increase year-over-year[5] - The basic earnings per share for the period was ¥0.2099, a 20.84% increase from the previous year[5] - Total operating revenue for Q3 2023 reached ¥562,949,775.72, an increase of 24% compared to ¥454,730,098.62 in Q3 2022[26] - Net profit for Q3 2023 was ¥133,282,845.33, representing a 39% increase from ¥95,700,799.15 in Q3 2022[27] - The total comprehensive income for the third quarter was CNY 133,281,033.15, an increase from CNY 95,694,299.86 in the previous year, representing a growth of approximately 39.2%[28] - The company reported a basic and diluted earnings per share of CNY 0.6075, compared to CNY 0.4329 in the same period last year, reflecting a growth of approximately 40.3%[28] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥1,752,096,715.51, a 5.58% increase from the end of the previous year[5] - Total assets as of September 30, 2023, amounted to ¥1,752,096,715.51, up from ¥1,659,522,369.65 at the start of the year[24] - Total liabilities increased to ¥158,049,758.99 from ¥147,620,954.99, reflecting a rise of 7%[24] - The company's equity attributable to shareholders rose to ¥1,551,450,217.96 from ¥1,469,331,795.05, an increase of 6%[24] Cash Flow - Cash flow from operating activities for the year-to-date was ¥143,534,071.82, showing a 59.07% increase compared to the same period last year[14] - The net cash flow from operating activities was CNY 143,534,071.82, up from CNY 90,233,402.40, indicating a year-over-year increase of about 59%[30] - The cash inflow from operating activities amounted to CNY 602,509,675.39, compared to CNY 502,688,365.01 in the previous year, marking an increase of approximately 19.8%[30] - The cash outflow from investing activities was CNY 1,404,539,094.13, down from CNY 2,483,845,443.48, indicating a reduction of about 43.5%[30] - The net cash flow from investing activities was -CNY 558,628,624.53, an improvement from -CNY 867,326,869.66 in the previous year, reflecting a decrease in cash outflow of approximately 35.5%[30] - The company experienced a foreign exchange impact on cash and cash equivalents of CNY 279,075.65, compared to CNY 1,544,138.94 in the previous year, indicating a decrease of about 81.9%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,201, with the top ten shareholders holding a combined 77.67% of the shares[16] - Shanghai Mingyue Industrial Co., Ltd. holds 55.09% of the shares, making it the largest shareholder[16] Business Operations and Market Strategy - The company reported a significant increase in trade receivables, which rose by 44.88% to ¥164,032,452.38, attributed to increased sales[9] - The company’s fixed assets increased by 50.00% to ¥219,969,334.23 due to the completion of expansion projects and new equipment purchases[9] - The company received government subsidies amounting to ¥1,031,780.37 during the quarter, contributing to its non-recurring gains[7] - The revenue from the lens business in Q3 reached 161.14 million RMB, representing a year-on-year growth of 26.7% (excluding export business) [20] - The PMC Ultra Bright series product saw a revenue increase of 77.3% year-on-year in Q3, while the 1.71 series product grew by 26.6% year-on-year [20] - The sales revenue of the "Easy Control" series products for the first three quarters of 2023 was 99.71 million RMB, marking a year-on-year increase of 74% [20] - The proportion of functional lenses in the overall product mix has further increased, with the three major star products accounting for over 50% of the revenue from conventional lenses [20] - The company has intensified brand promotion efforts, including appearances on CCTV's prime time news programs and large-scale eye care public welfare campaigns [20] - The company is actively expanding its market presence through various promotional activities, including events related to space exploration and partnerships with well-known medical institutions [20] - The penetration rate of myopia prevention lenses in the youth market remains low, indicating strong future growth potential as more companies enter the market [20] - The company has increased its marketing activities on social media platforms such as Douyin, Xiaohongshu, and Zhihu to drive sales growth [20] Research and Development - Research and development expenses for Q3 2023 were ¥16,976,361.63, compared to ¥15,094,476.82 in Q3 2022, marking an increase of 12%[27] Inventory Management - Inventory decreased to ¥80,345,028.43 from ¥89,732,910.50, a decline of 10%[23] Mergers and Acquisitions - The company did not report any new mergers or acquisitions during this quarter, focusing instead on internal growth strategies and product development[31]

本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：301101 证券简称：明月镜片 公告编号：2023-033 明月镜片股份有限公司 第二届监事会第七次会议决议公告 三、备查文件 1、第二届监事会第七次会议决议。 特此公告。 一、监事会会议召开情况 明月镜片股份有限公司（以下简称"公司"）第二届监事会第七次会议于 2023 年 10 月 23 日在公司会议室以现场表决方式召开。本次会议通知于 2023 年 10 月 11 日以专人送达、电话、微信等形式通知了全体监事。本次会议由监事会主席朱 海峰先生召集并主持，应出席公司会议的监事 3 人，实际出席公司会议的监事 3 人。会议召开符合《中华人民共和国公司法》、《公司章程》等规定，会议合法有 效。 二、监事会会议审议情况 经与会监事充分讨论，本次会议审议通过议案如下： （一）审议通过《关于<2023 年第三季度报告>的议案》； 经审核，监事会认为：董事会编制和审核公司 2023 年第三季度报告的程序 符合法律、行政法规和中国证监会的规定，第三季度报告内容真实、准确、完整 地反映了公司的实际情况，不存在任何 ...

明月镜片股份有限公司 独立董事关于第二届董事会第七次会议 相关事项的独立意见 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上市公司独立 董事管理办法》、《上市公司治理准则》、《深圳证券交易所创业板股票上市规则》、 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等有关规定，作为明月镜片股份有限公司（以下简称"公司"）的独立董事，基 于独立、客观判断的原则，现就相关事项发表如下独立意见： 一、关于聘任公司 2023 年年度会计师事务所的独立意见 立信会计师事务所（特殊普通合伙）具备相关业务审计从业资格，具有上市 公司审计工作的丰富经验和职业素养。鉴于该会计师事务所的总体实力、服务意 识等各方面均符合公司当前的审计工作要求，我们一致同意聘任立信会计师事务 所（特殊普通合伙）为公司 2023 年度审计机构，并同意将此议案提交公司股东 大会审议。 （以下无正文） （本页无正文，为《明月镜片股份有限公司独立董事关于第二届董事会第七次会 议相关事项的独立意见》之签署页） 张银杰（签字）____________ 傅仁辉（签字）____________ 孙 健（签字）________ ...

明月镜片股份有限公司 独立董事关于第二届董事会第七次会议 傅仁辉（签字）____________ 孙 健（签字）____________ 2023 年 10 月 20 日 相关事项的事前认可意见 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上市公司独立 董事管理办法》、《上市公司治理准则》、《深圳证券交易所创业板股票上市规则》、 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等有关规定，作为明月镜片股份有限公司（以下简称"公司"）的独立董事，基 于独立、客观判断的原则，现就相关事项发表事前认可意见如下： 一、关于聘任公司 2023 年年度会计师事务所的事前认可意见 经核查，我们认为：立信会计师事务所（特殊普通合伙）具备相关业务资质， 具备足够的独立性、专业胜任能力、投资者保护能力，具有丰富的为上市公司提 供审计服务的经验，能够满足公司 2023 年度审计工作要求，我们同意聘任立信 会计师事务所（特殊普通合伙）为公司 2023 年年度会计师事务所，并同意将该 议案提交公司第二届董事会第七次会议审议。 （以下无正文） （本页无正文，为《明月镜片股份有限公司独立董事关于第 ...

证券代码：301101 证券简称：明月镜片 公告编号：2023-036 明月镜片股份有限公司 关于召开公司 2023 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 明月镜片股份有限公司（以下简称"公司"）于 2023 年 10 月 23 日召开的第 二届董事会第七次会议审议通过了《关于召开公司 2023 年第二次临时股东大会 的议案》，决定于 2023 年 11 月 8 日（星期三）14:30 召开 2023 年第二次临时股 东大会，现将有关事项通知如下： 一、会议召开的基本情况 （一）会议届次：2023 年第二次临时股东大会 （二）会议召集人：董事会。公司第二届董事会第七次会议于 2023 年 10 月 23 日召开，审议通过了《关于召开公司 2023 年第二次临时股东大会的议案》， 同意召开本次股东大会。 （三）会议召开的合法性及合规性：本次董事会召开股东大会会议符合有关 法律、行政法规、部门规章、规范性文件和《公司章程》的相关规定。 （四）会议召开日期、时间： 1、会议召开时间：2023 年 11 月 8 日（星期三）14: ...

证券代码：301101 证券简称：明月镜片 公告编号：2023-032 明月镜片股份有限公司 第二届董事会第七次会议决议公告 二、董事会会议审议情况 经与会董事充分讨论，本次会议审议通过议案如下： （一）审议通过《关于<2023 年第三季度报告>的议案》； 表决结果：7 票同意；0 票反对；0 票弃权。 具体内容详见同日披露于巨潮资讯网（www.cninfo.com.cn）上的《2023 年第 三季度报告》。 （二）审议通过《关于聘任公司 2023 年年度会计师事务所的议案》； 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 明月镜片股份有限公司（以下简称"公司"）第二届董事会第七次会议于 2023 年 10 月 23 日在公司会议室以现场结合通讯的表决方式召开。本次会议通知于 2023 年 10 月 11 日以专人送达、电话、微信的方式通知了全体董事。本次会议由董事长 谢公晚先生主持，应出席会议董事 7 人，实际参加会议董事 7 人，公司监事、高级 管理人员列席会议。会议召开符合《中华人民共和国公司法》、《公司章程》等规定， 会议合法 ...

证券代码：301101 证券简称：明月镜片 公告编号：2023-035 截至 2022 年末，立信拥有合伙人 267 名、注册会计师 2,392 名、从业人员 总数 10,620 名，签署过证券服务业务审计报告的注册会计师人数 674 名。 立信 2022 年业务收入（经审计）46.14 亿元，其中审计业务收入 34.08 亿 元，证券业务收入 15.16 亿元。 2022 年度立信为 646 家上市公司提供年报审计服务，审计收费 8.17 亿元， 同行业上市公司审计客户 24 家。 明月镜片股份有限公司 关于聘任公司 2023 年年度会计师事务所的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 明月镜片股份有限公司（以下简称"公司"）于 2023 年 10 月 23 日召开了第 二届董事会第七次会议，审议通过了《关于聘任公司 2023 年年度会计师事务所 的议案》，董事会同意继续聘请立信会计师事务所（特殊普通合伙）（以下简称"立 信"）为公司 2023 年度审计机构。本议案尚需提交公司 2023 年第二次临时股东 大会审议，自股东大会审议通过之日起生效 ...

明月镜片股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------|-----------------------|------------------------------------------------------------------------------------------------------------------------------| | 投资者关系 | √特定对象调研 | | | 活动类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 | | | | □现场参观 | | | | □其他 | | | 参与单位 | 中金公司、 | Allianz Global Investors Luxembourg S.A、Alpines | | | | 、FIL HKCHAPLT、Goldman Sachs Asset Management International、JM GREAT | | | | CHINA FUND、Matthews International Capital Management,LLC、 | | | | ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥365,939,936.15, representing a 27.78% increase compared to ¥286,390,640.49 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥80,121,334.97, up 53.38% from ¥52,236,561.21 in the previous year[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥70,481,826.51, an increase of 81.56% compared to ¥38,819,244.58 in the same period last year[22]. - The net cash flow from operating activities was ¥94,584,559.32, reflecting a 55.17% increase from ¥60,956,040.83 in the previous year[22]. - Basic earnings per share rose to ¥0.3976, a 53.40% increase from ¥0.2592 in the same period last year[22]. - The company's total profit for the first half of 2023 was CNY 100.06 million, a 47.2% increase from CNY 67.97 million in the same period last year[178]. - The total comprehensive income for the first half of 2023 was 80.1 million, representing a 6.79% increase compared to the previous period[186]. - The company reported a significant increase in retained earnings, with a balance of 201,510,000 at the end of the period[193]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,702,413,138.81, a 2.58% increase from ¥1,659,522,369.65 at the end of the previous year[22]. - The total liabilities increased slightly to ¥148,625,002.62 from ¥147,620,954.99, showing a marginal rise of 0.7%[168]. - Cash and cash equivalents decreased significantly from ¥915,192,342.31 at the beginning of the year to ¥476,725,029.31, a decline of 47.9%[170]. - The total liabilities at the end of the reporting period were 550,230,000, showing effective management of financial obligations[193]. Research and Development - Research and development expenses rose by 26.92% to ¥11.26 million, compared to ¥8.87 million in the same period last year[61]. - The R&D expenditure for the first half of 2023 was 28.7 million, accounting for 5.11% of total revenue[186]. - The company has established partnerships with top research institutions to drive technological advancements, focusing on myopia prevention and functional optical lenses[48]. - As of June 30, 2023, the company holds 161 patents, including 25 invention patents, demonstrating its commitment to innovation and technology[49]. Market Strategy and Expansion - The company aims to become the leading brand in the Chinese lens market, focusing on brand promotion and channel expansion[35]. - The company plans to expand its presence in the medical channel, having completed the establishment of a dedicated team in 2022[35]. - The company is actively expanding its online presence with flagship stores on platforms like Tmall and JD, integrating online and offline sales channels[56]. - The company plans to enhance its mid-to-high-end product line capacity through fundraising projects, although there are risks of not achieving expected returns[89]. - The company plans to expand its market presence and invest in new product development, aiming for a 20% increase in market share by the end of 2024[186]. Environmental Responsibility - The company invested a total of ¥1,223,080.76 in environmental governance and protection during the reporting period[107]. - The company emphasizes a "high efficiency, low energy consumption" green production model to support national carbon reduction goals[108]. - The company has implemented a self-monitoring plan for pollutants, with results showing no exceedances of standards[103]. - The company has committed to reducing carbon emissions through energy management and resource conservation initiatives[108]. Shareholder and Dividend Information - The company plans to increase its dividend payout ratio to 20% in the upcoming fiscal year, enhancing shareholder returns[186]. - The company distributed cash dividends of RMB 3.00 per 10 shares and issued 5 bonus shares, totaling cash dividends of RMB 40,302,420 on May 23, 2023[110]. - The company has implemented a profit distribution policy to enhance shareholder returns and maintain good communication with investors[110]. Corporate Governance - The company has a robust internal control system to protect shareholder rights and ensure accurate information disclosure[109]. - The company has not experienced any significant litigation or arbitration matters during the reporting period[122]. - The company has not engaged in any asset or equity acquisition or sale transactions during the reporting period[125]. Product Development - The company launched the "Easy Control" series of myopia management lenses, which received professional recognition and increased sales confidence among customers[112]. - The company has launched a total of 18 SKUs in the myopia management lens category, maintaining a significant lead in product line richness[51]. - The "Light Control" series products amounted to CNY 54.81 million, showing a significant year-on-year growth of 76%[36]. Customer Engagement - As of June 30, 2023, the company had 2,504 direct sales customers and 46 distribution customers, with direct sales channel revenue of 224.68 million yuan, accounting for 61.40% of total revenue[43]. - The company has established a stable channel structure with tens of thousands of offline terminal stores, enhancing customer engagement through product tasting events and customer salons[54].

明月镜片股份有限公司 投资者关系活动记录表 编号：2023-002 | | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | 投资者关系活动类别 | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位 | 投资者网上提问 | | 时间 | 2023年5月25日 | | 地点 | 价值在线（https://www.ir-online.cn/）网络互动 | | | 董事长谢公晚 | | 上市公司接待人员姓名 | 董事会秘书兼副总经理曾哲 | | | 独立董事张银杰 | | | 财务总监尉静妮 | | | 1 .公司未来对智能眼镜有没有规划？ | | | 答:公司目前在小米有品旗舰店售卖的智能眼镜sasky具有语音 | | | 助手功能，可以语音唤醒SIRI、小艺、小爱同学，并具有接打电 | | | 话、导航等功能。公司在立足主营业务的同时积极关注布局眼视光 | | | 行业前瞻性技术。 | | | 2 .请问公司是否有在多家医院做轻松控防控效果临床的计划？ | | | 感谢！ | | | 答:202 ...